The systematic development of a complex intervention: HealthMap, an online self-management support program for people with HIV by Millard, Tanya et al.
RESEARCH ARTICLE Open Access
The systematic development of a complex
intervention: HealthMap, an online self-
management support program for people
with HIV
Tanya Millard1,2* , Sarity Dodson3, Karalyn McDonald1, Karen M. Klassen1, Richard H. Osborne4,
Malcolm W. Battersby5, Christopher K. Fairley6 and Julian H. Elliott1,2
Abstract
Background: Despite persistent calls for HIV care to adopt a chronic care approach, few HIV treatment services
have been able to establish service arrangements that prioritise self-management. To prevent cardiovascular and
other chronic disease outcomes, the HealthMap program aims to enhance routine HIV care with opportunities for
self-management support. This paper outlines the systematic process that was used to design and develop the
HealthMap program, prior to its evaluation in a cluster-randomised trial.
Methods: Program development, planning and evaluation was informed by the PRECEDE-PROCOEDE Model and
an Intervention Mapping approach and involved four steps: (1) a multifaceted needs assessment; (2) the
identification of intervention priorities; (3) exploration and identification of the antecedents and reinforcing
factors required to initiate and sustain desired change of risk behaviours; and finally (4) the development of
intervention goals, strategies and methods and integrating them into a comprehensive description of the
intervention components.
Results: The logic model incorporated the program’s guiding principles, program elements, hypothesised causal
processes, and intended program outcomes. Grounding the development of HealthMap on a clear conceptual base,
informed by the research literature and stakeholder’s perspectives, has ensured that the HealthMap program is targeted,
relevant, provides transparency, and enables effective program evaluation.
Conclusions: The use of a systematic process for intervention development facilitated the development of an
intervention that is patient centred, accessible, and focuses on the key determinants of health-related outcomes
for people with HIV in Australia. The techniques used here may offer a useful methodology for those involved in
the development and implementation of complex interventions.
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Background
Globally, the population of people with HIV is both in-
creasing and aging. The extended life expectancy and
sustained incidence rates of HIV has led to an increased
prevalence of HIV in Australia. According to recent esti-
mates, there were 25,313 people living with HIV in
Australia in 2015, compared with 15,310 in 2005 [1]. Of
these, 19,051 (75%) were estimated to be receiving
anti-retroviral therapy (ART) and 17,544 (69%) were
virologically supressed [1]. Survival rates have improved
significantly in settings with access to antiretroviral ther-
apies and life expectancy can be equal to that seen in
the general population [2, 3]. However, people with HIV
experience high rates of non-AIDS related morbidities
including cardiovascular disease (CVD), cancer, liver and
renal disease [4–6]. Such morbidities are now more
frequently experienced by people with HIV than
AIDS-related events and carry a higher risk of death [6].
Further, they are occurring at an increased frequency
compared with the general population. While evidence
supports contributions from HIV itself, ART toxicity,
and health behaviours [6–9], the most prominent factor
behind the increased incidence is a high prevalence of
traditional CVD risk factors in people with HIV, in par-
ticular smoking and dyslipidaemia [7, 10–14].
Concern has been raised that while primary care pro-
viders are adequately meeting the standards of care for
HIV management, more attention needs to be focused
on the detection, prevention, and management of co-
morbid conditions [15, 16]. Reviews of HIV care services
across Australia have highlighted a substantial gap be-
tween existing HIV care services and delivery, and the
transition of HIV into a chronic disease dominated by
comorbid conditions [17, 18]. An audit of patients com-
mencing ART at several hospital and primary care sites
in Australia found that while concordance between prac-
tice and guideline recommendations was generally high
for HIV treatment activities (> 70%), concordance with
activities in relation to chronic and comorbidities was
quite low (< 50%) [17, 18]. These reports have
highlighted the importance of service coordination and
integration, and adopting a self-management approach.
They also reiterate the role of information and commu-
nication systems in support of effective service delivery
[17, 18]. The goals of these activities are to reduce the
prevalence of modifiable risk factors, along with early
identification and improved management [6].
Self-management includes a range of attitudes, behav-
iours and skills to manage the impact of chronic condi-
tions on all aspects of living [19]. Self-management
support includes the social, physical and emotional sup-
port provided by others (including health professionals,
significant others and carers) to assist a person in the
management of their condition [19]. Research in chronic
disease has demonstrated the benefits of integrating
self-management programs into the primary care visit
[20–22]. There are numerous self-management pro-
grams available to people with chronic diseases, but
people with HIV face unique challenges including
stigma, issues around disclosure of HIV status, negotiat-
ing intimate relationships and transmission prevention
[23–25]. For people with HIV, stigma shapes agency and
engagement with health, and decisions concerning
health behaviours are often driven by perceived emo-
tional and social benefit, which are firmly embedded in
concerns of disclosure and stigma [25]. It is clear that
these complex issues require targeted attention in order
to be adequately addressed and managed [26, 27].
Self-management interventions for people with HIV
have been found to improve adherence to medica-
tions, mental health and quality of life, and can po-
tentially mitigate the negative health effects of
comorbid conditions [27–30]. Only a few HIV specific
self-management programs have been developed [28,
29, 31], and linkages between these programs and
existing HIV treatment programs are rarely estab-
lished. The two HIV self-management programs cur-
rently available in Australia are the Stanford Program
offered through the Bobby Goldsmith Foundation in
Sydney, and the Flinders Program of chronic condi-
tion management that has been used in the HIV Out-
reach clinic in South Eastern Sydney, both of which
are delivered in a group face-to-face format. Other
programs available around Australia, which include
self-management elements such as peer support and
life coaching, are offered through community organi-
sations. However these services are largely targeted
towards and accessed by those who are newly diag-
nosed. Barriers to traditional face-to-face programs
include location, work hours and lack of association
with community organisations delivering these
programs. Stigma and disclosure are additional prom-
inent and critical barriers for people with HIV acces-
sing community supports and face-to-face programs
[32, 33].
Self-management interventions are increasingly being
delivered online in order to address some of these bar-
riers to participation. Growing evidence suggests the
effectiveness of online self-management programs for
people with chronic conditions including asthma,
arthritis, diabetes, neurological conditions and cardio-
vascular disease [34–39]. Online interventions may offer
several advantages to people with HIV, including
time, convenience, overcoming isolation and anonymity
[37, 40–42]. A recent Australian randomised study found
evidence that participation in a group based online
self-management program resulted in short-term im-
provements in quality of life, self-efficacy and
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self-management skills in gay men living with HIV, sup-
porting the feasibility and potential efficacy of these pro-
grams [43].
We hypothesised that integration of self-management
support into routine clinical consultations may offer an
opportunity to reduce the risk of cardiovascular disease
and other comorbidities and improve the psychosocial
wellbeing of people with HIV. HealthMap was established
to improve these outcomes by linking the usual interac-
tions of the existing care team to a set of self-management
support opportunities. Specifically, HealthMap aimed to
create a model of care for people with HIV that incudes
use of an interactive shared health record and online and
phone-based self-management support.
While researchers have repeatedly deplored the lack of
transparency in the design and development of complex
interventions, little attention continues to be given to
reporting development approaches, or to the publication
of underlying program logic models that detail the
hypothesised relationship between outcomes and inter-
vention components. The lack of such planning and
careful intervention design increases the risk of interven-
tions being weak or unable to be implemented [44]. The
Medical Research Council highlights the need for more
focus on early development work and piloting, inte-
grated process and outcome evaluation and ensuring in-
terventions are tailored to specific contexts [45].
Implementation research is strengthened through careful
application and testing of theory; focusing on the inter-
action between innovation and the contexts in which
they take place; engaging stakeholders as a part of the
research process; including varied professional disci-
plines and evaluation methods; and detailed documenta-
tion [46]. We therefore undertook a systematic approach
to the development of the HealthMap program. This
paper describes this systematic process and its outcome.
Methods
The PRECEDE-PROCEDE Model [47] and Intervention
Mapping [48] informed program development, planning
and evaluation and this process included four steps. The
first step (needs assessment) involved the identification
of priority community needs, desires, capacities,
strengths and resources via concept mapping workshops,
online surveys and interviews with people with HIV and
HIV care providers. Step 2 (identification of intervention
priorities) involved the identification of behavioural, epi-
demiological and environmental risk factors based on
the findings of the needs assessment and the existing lit-
erature. Step 3 (identifying mechanisms of change) in-
volved the identification of the antecedents and
reinforcing factors required to initiate and sustain de-
sired change of risk behaviours and the development of
a program logic model. Existing research guided the
probable causal and protective factors to be targeted by
the HealthMap program and clinical, provider and con-
sumers advisors were involved in the refinement of the
project logic model. Step 4 entailed translating these
determinants into intervention goals, strategies and
methods (drawing on existing research literature and ex-
pert opinion) and integrating them into a comprehensive
description of the intervention components.
Results
Step 1: Needs assessment
We began with a systematic approach of exploring and
obtaining information from key informants and stake-
holders with broad experiences pertaining to HIV, and
in the development and implementation of
self-management interventions. Concept mapping was
identified as a useful process to gather insights and or-
ganise information about what people with HIV in
Australia perceive they need in order to live with and
manage their condition [49, 50]. To expand the reach of
the needs assessment, the findings from concept map-
ping were used to construct a survey that was distrib-
uted to health providers and people with HIV. A
detailed description of the HealthMap needs assessment
including the concept mapping workshops has been
published [51].
Briefly, in three concept mapping workshops, partici-
pants were asked a broad seeding statement: “What do
people with HIV infection need to be able to live with
and manage their condition, and its impact on their life,
as a chronic condition that they will probably live with
over decades rather than years?” Participants merged
and grouped their responses into coherent groups and a
computer program generated ‘cluster maps’ and a list of
statements according to cluster membership. Seven
broad themes were identified: (1) clinical science re-
search and development; (2) information and support;
(3) personal situation; (4) healthcare quality; (5) access
to services; (6) access to services specific to ageing; (7)
social justice. Social support and self-management were
also emphasised as priority areas [51].
The data obtained from these workshops informed an
online survey distributed to people with HIV (n = 300)
and HIV care providers (n = 107) across Australia. The
results from the survey revealed the most important
need identified by people with HIV was to feel able to
make informed choices. This was also rated highly by
health professionals [51].
Consistent with previous research, findings from the
needs assessment emphasised the importance of psycho-
social supports, mental health support, social services/sup-
ports and chronic condition management support [43, 52].
Stigma remained a consistent issue reported by people with
HIV and health professionals. The desire for integration
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and coordination of care, and a broader focus on lifestyles
and other health concerns was also expressed.
Qualitative research with people with HIV (n = 33) was
also conducted as part of the needs assessment to ex-
plore their practices and motivations in maintaining and
managing their health within the social and emotional
contexts of their lives [25]. Findings from this research
again emphasised the overriding centrality of stigma in
the lives of people with HIV and their interaction with
health care systems [25].
Step 2: Identification of intervention priorities
Drawing on the needs identified in step one, and prior-
ities and circumstances of people with HIV living in
Australia detailed in the existing literature, the research
team began to construct a list of potential intervention
targets. These were reviewed in light of the program
focus agreed with funders: 1) a focus at the level of clin-
ical intervention, in particular leveraging the strong
existing relationship between people with HIV and their
primary HIV care providers, rather than focus on whole
of community interventions; 2) reduction of cardiovas-
cular disease risk as the primary outcome; and 3) use of
technology to increase program reach and engagement.
A set of guiding principles were also developed during
Step 2 to support decision-making throughout program
design and implementation:
1. Recognising and supporting the role of other
significant people;
2. Respect and non-discrimination;
3. Services seeking to optimise choices;
4. Responsiveness to individual needs;
5. Recognition of social determinants of health;
6. A holistic view of health and a satisfying life;
7. Recognition of the impact of social perceptions of
HIV and people with HIV;
8. Recognition that HIV is an illness with
ramifications in many areas of life;
9. Focus on affirmative, hope and confidence building
approaches; and
10. Feasible and sustainable for patient and provider.
Study investigators and the research team participated
in a workshop where they reviewed intervention prior-
ities alongside the results of the needs assessment and
the existing literature. The aim was to achieve consensus
on the target behaviours and outcomes and discuss pos-
sible intervention targets. Ideas were discussed and re-
fined until clear intervention targets were identified. As
noted above, cardiovascular disease was identified prior
to program design as the primary outcome of focus. Due
to the large burden of anxiety and depression in people
with HIV, the strong association between depression,
social isolation and CVD risk factors [53, 54], and the
moderating effects of mental health on self-management
behaviours [55, 56], depression and anxiety were identi-
fied as important secondary outcomes. More distally, life
expectancy and health-related quality of life were identi-
fied as the intended long-term outcomes. Social isola-
tion, HIV and its treatment, and other chronic
conditions and their treatment were also identified as
having the potential to be influenced by the intervention.
The key intervention targets are highlighted in Fig. 1.
Relevant proximal clinical factors relating to risk of
cardiovascular disease (i.e. cholesterol levels, weight, and
blood pressure), as well as behaviours and social factors
linked to cardiovascular disease risk and common men-
tal illnesses were identified from the research literature
(see Fig. 2) [53–55, 65–67]. The primary and secondary
outcomes were then used as a basis for identification of
clinical, behavioural and social factors the program
would need to influence. Among behavioural influences,
smoking was identified as particularly important to ad-
dress given the high prevalence in people with HIV and
the strong link with cardiovascular risk.
Step 3: Identifying mechanisms of change – How the
program needs to function in order to positively
influence the target behaviours and social factors
Based on the findings from step one and two, a program
logic model was developed by an interdisciplinary team of
researchers for the HealthMap intervention informed by
existing research across a diverse range of fields (health
education, coaching, self-management interventions,
chronic disease management, and HIV-management).
Specifically, existing research guided the probable causal
and protective factors that could be targeted by the
HealthMap program and the opportunities for the inter-
vention [57]. Clinical, provider, and consumer advisors to
Fig. 1 Intended Intervention Outcomes
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the project reviewed and supported refinement of the pro-
gram logic model (see Fig. 2).
The program logic model was used in conjunction
with a thorough literature review and consultation with ex-
perts in the fields of behaviour change, self-management
and online intervention, to identify underlying mechanisms
responsible for linkages between program elements. This
process described exactly what works, for whom, in what
circumstances, and how, giving insight into the mecha-
nisms mediating the effects of the individual and service
provider change process.
The mapping of proposed mechanisms of action
allowed the identification of several intervention require-
ments that were expected to maximise the effectiveness
of HealthMap (as an online self-management program
for reducing CVD risk in people with HIV). These
requirements included: grounding the intervention in
theory [45, 58, 59]; tailoring content and delivery mode
to the individual; integrating it into primary care visits
[20]; the ability to provide multiple opportunities for en-
gagement; and the ability to encourage goal setting and
problem solving [60, 61].
Fig. 2 Program Logic
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The Chronic Care Model served as the conceptual
basis for the overall intervention [62]. The identification
of mechanisms of change that underpin the design of
the HealthMap program was informed by several com-
plementary behaviour change theories, including Social
Cognitive Theory [63], the Transtheoretical Model [64]
and concepts derived from Chronic Disease Self
Management models. Grounding the intervention in be-
haviour change theory combined with outcomes linked
to theory-based constructs facilitated our understanding
of causal pathways leading to potential intervention
effects.
Enablers of change relating to specific behaviours of
interest
Smoking cessation
Smoking cessation strategies were informed by the
PRIME theory of motivation [65] and drew upon smok-
ing cessation behaviour change techniques [59]. The
behaviour-specific enablers we aimed to target for smok-
ing cessation included using nicotine replacement ther-
apies; minimising the motivation to smoke; maximising
skill and capacity for self-control; optimising the use of
quit medications; and optimising the use of adjunctive
activities [65].
Support for smoking cessation includes a combination
of behavioural support and medications. Modelling, re-
lapse prevention/coping planning, facilitation of social
comparison, goal setting, action planning and provision
of feedback were identified as important non-medication
based intervention components [66].
Interventions informed by theory and using a greater
number of behaviour change techniques have been
found to be more effective than those which do not [66].
Therefore, HealthMap aimed to provide numerous
opportunities for participants to access a variety of
smoking cessation supports by encouraging doctors to
address smoking status at every appointment and pro-
vide medication, referral to a nationally-support “Quit
Line”, health coaching and goal setting.
Blood pressure and cholesterol management
Behaviour-specific targets for blood pressure and chol-
esterol management included optimising use of medica-
tion; and optimising use of health and social services.
Treatment to manage blood pressure and cholesterol
includes a combination of lifestyle advice, behavioural
support and medication [67]. Lipid and blood pressure
lowering pharmacotherapy reduces both total mortality
and mortality from CVD [68, 69], while lifestyle changes
in nutrition, physical activity and smoking status also
contributes to reducing CVD risk. HealthMap aimed to
provide opportunities for participants to monitor and
better understand their blood pressure and cholesterol
levels, and encouraged behavioural modifications and
goal setting. HealthMap prompted doctors to monitor
and address blood pressure and cholesterol management
at every appointment.
Depression, anxiety and stress management
With regards to stress, mood, anxiety and fatigue man-
agement, we identified the following behaviour-specific
enablers: cognitive behaviour therapy; optimising use of
medications; optimising social engagement; peer support
and optimising use of health and social services. To
facilitate the adoption of these behaviour changes the
HealthMap program focused on: (1) developing skills;
(2) developing knowledge; (3) developing resources and
supports; and (4) developing constructive attitudes and
approaches. Key engagement approaches were identified
as: education; persuasion; training; incentivisation; en-
ablement and modelling. See Fig. 2 for a summary of the
identified mechanisms of change.
Step 4: Identifying intervention components
Intervention mapping was then undertaken, integrating
invention goals, change strategies and methods into a
comprehensive intervention model. This step drew on
existing research literature on effective interventions
able to influence CVD risk and depression, anxiety and
stress, and the established guiding principles of the pro-
gram. Taxonomies of behaviour change interventions
were used to identify a set of intervention components
that were then organised into a feasible and appropriate
program design (see Fig. 3). This map presents the spe-
cific intervention components included in the Health-
Map program and how they would be delivered, by
whom, using what technology supports. It also
highlighted the behaviour change techniques HealthMap
would use to elicit desired changes and outcomes.
The HealthMap model has been described in the study
protocol [70]. Briefly, the model included (1) new oppor-
tunities for people with HIV to discuss their health
status and goals with their doctor using the HealthMap
shared health record; (2) access for people with HIV to
their own health record and contextual health informa-
tion; and (3) self-management support delivered by
health coaches, online and via telephone. The program
was designed to be delivered during routine clinic visits
and post-clinic visit, both offering unique opportunities
to engage participants in the self-management of their
condition tailored to the individual (Fig. 3).
In-visit
During the clinic visit, the doctor and patient can use
the HealthMap platform as a tool to access and discuss
recent laboratory results and identify health issues and
areas where the patient is interested in making changes.
The HealthMap user interface prompts people with HIV
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and their doctors to discuss recent laboratory results in
the context of their overall health, including CVD,
mood, stress and anxiety and nudge the discussion to-
wards an exploration of the opportunities for and bene-
fits of addressing these health issues. The person with
HIV and their doctor can identify, document and discuss
health priorities on the HealthMap platform and doctors
can refer patients to health coaching. Information can be
viewed by patients, coaches and providers. It is intended
that, by utilizing healthcare consultations, the Health-
Map platform provides convenient access to patient
health information, facilitating doctors and their patients
to more frequently and easily engage in conversations
about the patient’s health status and broader health pri-
orities. Integrating self-management support services
with patients’ usual primary health care is intended to
supplement health promotion activities in the health
clinic and support patients’ ability to progress towards
their health-related goals.
Post-visit
Participants are encouraged to use the HealthMap portal
outside of clinic visits to view their lab results and access
information about their health priorities and goals and
strategies. HealthMap places emphasis on the provision
of information about the link between behaviour and
health, prompting patients to self-monitor their behav-
iour. Participants can create and update action plans and
document progress towards their health goals. Addition-
ally, patients can access links to additional health
information and can document areas of concern to dis-
cuss with their doctor at their next visit.
Participants also have access to self-management
coaching, consisting of telephone calls with a health pro-
fessional supplemented by email support and an optional
series of online learning modules which included com-
ponents of the Flinders Program care planning process
[71]. The key methods of the HealthMap coaching pro-
gram include psycho-education, cognitive behavioural
therapy (CBT), motivational interviewing, and goal set-
ting. During coaching appointments, participants review
laboratory results, set goals, identify barriers and facilita-
tors to success and are supported in their goal setting
and achievement.
Discussion
This paper outlines the development of a complex inter-
vention targeting CVD risk reduction in people with
HIV in Australia. From inception it was agreed that
HealthMap was to be delivered at the level of the clinic,
focus on CVD risk reduction as the primary outcome
and use technology to increase program reach and
engagement. A multifaceted needs assessment identified
depression, anxiety and stress as key secondary out-
comes that are key determinants of quality of life, and
also mediators of engagement with health programs.
Proximal clinical factors relating to risk of CVD as well
as behaviours and social factors linked to depression,
anxiety and stress or CVD were identified from the lit-
erature, with smoking emerging as the key priority given
Fig. 3 HealthMap Intervention Model and Components
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the strong link with CVD and high prevalence of
smokers among people with HIV.
Using grounded data from concept mapping with
people with HIV as well an established theoretical basis
including Social Cognitive Theory, the Transtheoretical
Model and concepts derived from Chronic Disease Self
Management models, the underlying mechanisms con-
tributing to the primary outcome and mechanisms re-
sponsible for linkages between program elements were
explored. These informed the construction of a program
logic model. The model guided our consideration of evi-
dence relating to the need to address CVD prevention
and risk reduction in people with HIV; the probable
causal and protective factors that could be targeted by
the HealthMap program; and the opportunities for inter-
vention. The final step in intervention development
drew on existing literature, the established guiding prin-
ciples of the program and taxonomies of behaviour
change interventions to identify intervention compo-
nents and behaviour change techniques HealthMap uses
to elicit desired change and outcomes.
There are several limitations to this study. Firstly, the
relatively short time frame of the project meant that
while a wide range of literature was considered, formal
literature reviews were not conducted to inform the de-
velopment of the HealthMap program. Secondly, the
program design was restricted by pre-defined constraints
including the focus of the intervention on CVD risk, the
mode of delivery (technology based intervention deliv-
ered at the level of the clinic) and the trial design. The
intervention priorities and componenets may have been
different in the absence of these restrictions. A further
potential limitation is the generalizability of the Health-
Map program in other settings and countries. Using the
Precede-Proceed Model and Intervention Mapping was
both a comprehensive and conceptually sound method
of intervention development. Due to significant overlap
between frameworks for health intervention planning,
the application of an alternative framework would un-
likely result in a different intervention model or
functions.
Conclusion
In this systematic process, evidence and theory were
used in combination with clinical and program design
experience to construct an intervention that responds to
the expressed priorities of people with HIV in Australia,
is comprehensive and feasible, and could achieve the
proposed outcomes. The use of a systematic process for
intervention development facilitated the development of
an intervention that is patient centred, accessible, and
focuses on the key determinants of health-related out-
comes for people with HIV in Australia. The techniques
used here may offer a useful methodology for those
involved in the development and implementation of
complex interventions. Trialling this intervention will
provide valuable information on the feasibility, accept-
ability and effectiveness of this innovative approach to
HIV management.
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